Active Not Recruiting NA INTERVENTIONAL 2-arm NCT05735912

EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) (ERASIN-RCT)

Endoscopic Ultrasound-guided RAdiofrequency Ablation Versus Surgical Resection for the Treatment of Pancreatic INsulinoma: a Multicenter Randomized Controlled Trial

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Conditions Pancreatic Insulinoma

Interventions Endoscopic ultrasound-guided radio frequency ablation Surgery

Updated 6 times since 2023 Last updated: Jan 11, 2026 Started: Mar 1, 2023 Primary completion: Oct 31, 2028 Completion: Oct 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05735912, this NA trial focuses on Pancreatic Insulinoma and remains ongoing. Sponsored by Azienda Ospedaliera Universitaria Integrata Verona, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jan 2025 — Feb 2026 [monthly]

Recruiting NA
Sep 2024 — Jan 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Mar 2023 — Apr 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera Universitaria Integrata Verona

Data source: Azienda Ospedaliera Universitaria Integrata Verona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Verona, Italy